MBM-17 is a potent NIMA-related kinase 2 (Nek2) inhibitor with an IC50 value of 3 nM; it exhibits antitumor activity by inducing cell cycle arrest and apoptosis, thereby inhibiting cancer cell proliferation, and shows no significant toxicity in mice.